apixaban stada 5 mg
stada arzneimittel ag, nemecko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
apixaban stada 2,5 mg
stada arzneimittel ag, nemecko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
apixaban sandoz 5 mg
sandoz pharmaceuticals d.d., slovinsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
lunsumio
roche registration gmbh - mosunetuzumab - lymfóm, folikulárny - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastické činidlá - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
vyvgart
argenx - efgartigimod alfa - myasthenia gravis - imunosupresíva - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.
apixaban sandoz 2,5 mg
sandoz pharmaceuticals d.d., slovinsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
sugammadex zentiva 100 mg/ml injekčný roztok
zentiva, k.s., Česká republika - sugamadex - 19 - antidota, detoxicantia
aboxoma 5 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)